204 related articles for article (PubMed ID: 3172360)
1. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of estramustine and estromustine in adipose tissue of rats and humans.
Gunnarsson PO; Andersson SB; Sandberg AA; Ellman M
Cancer Chemother Pharmacol; 1991; 28(5):361-4. PubMed ID: 1914079
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
Gunnarsson PO; Forshell GP; Fritjofsson A; Norlén BJ
Scand J Urol Nephrol; 1981; 15(3):201-5. PubMed ID: 7323739
[TBL] [Abstract][Full Text] [Related]
5. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
[TBL] [Abstract][Full Text] [Related]
6. Impairment of estramustine phosphate absorption by concurrent intake of milk and food.
Gunnarsson PO; Davidsson T; Andersson SB; Backman C; Johansson SA
Eur J Clin Pharmacol; 1990; 38(2):189-93. PubMed ID: 2338118
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.
Gunnarsson PO; Andersson SB; Johansson SA; Nilsson T; Plym-Forshell G
Eur J Clin Pharmacol; 1984; 26(1):113-9. PubMed ID: 6714283
[TBL] [Abstract][Full Text] [Related]
8. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
9. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
Bergenheim AT; Gunnarsson PO; Edman K; von Schoultz E; Hariz MI; Henriksson R
Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP
Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
[TBL] [Abstract][Full Text] [Related]
11. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
Björk P; Jönsson U; Andrén-Sandberg A
Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
[TBL] [Abstract][Full Text] [Related]
12. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Wang LG; Liu XM; Kreis W; Budman DR
Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
[TBL] [Abstract][Full Text] [Related]
13. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
14. Estramustine phosphate: plasma concentrations of its metabolites following oral administration to man, rat and dog.
Dixon R; Brooks M; Gill G
Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):17-29. PubMed ID: 7360997
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
[TBL] [Abstract][Full Text] [Related]
16. Expression of an estramustine-binding associated protein in human lung cancer cell lines.
Bergh J; Björk P; Westlin JE; Nilsson S
Cancer Res; 1988 Aug; 48(16):4615-9. PubMed ID: 2840198
[TBL] [Abstract][Full Text] [Related]
17. Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013L.
Kruse E; Johansson SA; Hartley-Asp B; Gunnarsson PO
Biochem Pharmacol; 1988 Aug; 37(16):3161-7. PubMed ID: 3401247
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan.
Yamanaka H; Imai K; Yuasa H; Shida K
Prostate; 1981; Suppl 1():95-102. PubMed ID: 7043423
[TBL] [Abstract][Full Text] [Related]
19. Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
Hoisaeter PA; Bakke A
Semin Oncol; 1983 Sep; 10(3 Suppl 3):27-33. PubMed ID: 6364363
[No Abstract] [Full Text] [Related]
20. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
